Acadia Healthcare (NASDAQ:ACHC) Hits New 1-Year Low – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price reached a new 52-week low on Thursday . The company traded as low as $39.60 and last traded at $39.90, with a volume of 51596 shares changing hands. The stock had previously closed at $39.83.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft upped their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. KeyCorp started coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Monday, November 4th. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $86.67.

Acadia Healthcare Trading Down 0.5 %

The company has a market cap of $3.68 billion, a price-to-earnings ratio of 13.06, a PEG ratio of 1.78 and a beta of 1.33. The firm has a 50 day moving average price of $59.60 and a two-hundred day moving average price of $66.10. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the prior year, the company earned $0.91 EPS. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. William Blair Investment Management LLC boosted its holdings in Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter. Point72 Asset Management L.P. boosted its holdings in Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after acquiring an additional 1,650,040 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Acadia Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after acquiring an additional 77,509 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Acadia Healthcare by 2.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,127,061 shares of the company’s stock worth $71,467,000 after acquiring an additional 29,936 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in shares of Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after purchasing an additional 1,055,894 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.